000 | 01893 a2200577 4500 | ||
---|---|---|---|
005 | 20250514011026.0 | ||
264 | 0 | _c20011018 | |
008 | 200110s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeiner, D M | |
245 | 0 | 0 |
_a5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 2001 |
||
300 |
_a268-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aGTP-Binding Proteins _xmetabolism |
650 | 0 | 4 | _aGene Amplification |
650 | 0 | 4 |
_aHead Movements _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 | _aQuantitative Structure-Activity Relationship |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReceptor, Serotonin, 5-HT2A |
650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
650 | 0 | 4 |
_aReflex, Startle _xdrug effects |
650 | 0 | 4 |
_aSerotonin Receptor Agonists _xpharmacology |
700 | 1 | _aBurstein, E S | |
700 | 1 | _aNash, N | |
700 | 1 | _aCroston, G E | |
700 | 1 | _aCurrier, E A | |
700 | 1 | _aVanover, K E | |
700 | 1 | _aHarvey, S C | |
700 | 1 | _aDonohue, E | |
700 | 1 | _aHansen, H C | |
700 | 1 | _aAndersson, C M | |
700 | 1 | _aSpalding, T A | |
700 | 1 | _aGibson, D F | |
700 | 1 | _aKrebs-Thomson, K | |
700 | 1 | _aPowell, S B | |
700 | 1 | _aGeyer, M A | |
700 | 1 | _aHacksell, U | |
700 | 1 | _aBrann, M R | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 299 _gno. 1 _gp. 268-76 |
|
999 |
_c11483192 _d11483192 |